StonvexLoading…
StonvexStonvexStonvexCore line items from NPKI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $277.04M | $217.49M | $207.65M | $192.99M |
Operating Income | $46.78M | $32.35M | $22.94M | $6.53M |
Net Income | $38.94M | $-150.26M | $14.52M | $-20.83M |
EPS (Diluted) | $0.45 | $-1.72 | $0.16 | $-0.22 |
Total Assets | $441.76M | $393.68M | $642.34M | $714.88M |
Total Liabilities | $90.60M | $67.19M | $226.97M | $291.85M |
Cash & Equivalents | $5.14M | $17.76M | $789.00K | $86.00K |
Free Cash Flow OCF − CapEx | $26.32M | $-5.36M | $70.77M | $-53.29M |
Shares Outstanding | 90.13M | 111.67M | 111.67M | 111.45M |